Navigation Links
Blood Protein may Hold Key to Why Healthy People Get Heart Attacks

Boffins have identified a blood protein myeloperoxidase (MPO) secreted by white blood cells, that both signals inflammation and releases a bleach-like substance that damages the cardiovascular system, which might be a clue to why apparently healthy persons could be at high risk of heart attacks.

The study was conducted by a team of researchers led by Matthijs Boekholdt at the Academic Medical Center in Amsterdam, the Netherlands.

Earlier studies in patients with chest pain and heart disease have linked elevated levels of MPO with those at highest risk for a heart attack.

As part of the study, to examine the relationship of MPO to cardiovascular risk in apparently healthy individuals, researchers recruited healthy people living in Norfolk, United Kingdom, between 1993 and 1997, as part of a larger community-based research program known as the European Prospective Investigation Into Cancer and Nutrition (EPIC) and took their baseline blood samples and froze it for future analysis.

After an average of eight years, 1,138 EPIC-Norfolk participants had been admitted to the hospital or died from the effects of coronary artery disease (CAD), including heart attack.

The researchers matched these patients with study participants who remained healthy throughout the follow-up period, selecting those of the same gender and similar ages and enrolment times.

Researchers found that the average blood levels of MPO were significantly higher in those who developed heart disease than in those who remained healthy.

The study suggested that although MPO is intended to kill harmful bacteria, it might instead inflame the body's arteries and cripple protective substances in the blood.

Elevated MPO levels signalled increased risk even in those with acceptable levels of LDL cholesterol, HDL cholesterol or C-reactive protein, a widely acknowledged marker of inflammation.
'"/>




Page: 1 2

Related medicine news :

1. Recommendations for Treatment of Blood Pressue
2. Blood Cells Capable of Regenerating Liver
3. Blood clots likely in long travel
4. Hemochromatosis Patients Blood is Safe
5. Blood transfusions beneficial after heart attacks
6. Blood Pressure Drug may slow wasting in burn victims
7. Levels Of Blood Proteins May Help Heart Disease Care
8. Blood test may identify ovarian cancer
9. A Blood test for suicide risk?
10. Blood Pressure Drugs maintain muscle strength
11. Blood test diagnoses heart failure in short time
Post Your Comments:
(Date:10/13/2008)...eading Content Rights Management System, Supports... Content Spend, WEST CHESTER, Pa., Oct. 13 /PRNew...ding global pharmaceutical manufacturer has integr...primary platform for the,secure distribution, data...cs for their new product video content. Imperium i...
(Date:10/13/2008)...swire/ -- The National Coalition for,Quality Color...ncerns over,the National CT Colonography Study pub...Medicine. The evidence must be closely evaluated, ...y is not without significant,potential risks. The ...py,remains the "Gold Standard" for colorectal canc...
(Date:10/13/2008)...blem in daily life, survey shows, PORTLAND, Ore.,...three-quarters of people living with psoriasis say...e, according to a National Psoriasis,Foundation 20...viduals with psoriasis and psoriatic arthritis,als...ly lives, shapes their,feelings about themselves a...
(Date:10/13/2008)...swire/ -- During the Pri-Med New York,conference a...are providers,took a 20-question quiz prepared by ...n Somerset, NJ. The quiz tested basic knowledge of..., EMR software, and healthcare,administration., T... The average number,of correct answers was only 7....
Breaking Medicine News(10 mins):Health News:Global Pharma Integrates Imperium(TM) to Support Launch Content ROI Initiatives! 2Health News:National Coalition for Quality Colorectal Cancer Screening and Care Conveys Concerns over CT Colonography 2Health News:National Coalition for Quality Colorectal Cancer Screening and Care Conveys Concerns over CT Colonography 3Health News:National Psoriasis Foundation Releases 2008 Study Results 2Health News:MTBC Practice Management Quiz Sends Message to Doctors: There is Real Room for Improvement or a Need to Outsource 2
... UK Patricia Hewitt, will call for better financia... for a halt to the existing handout culture.// As ...rvival of the health trusts will depend upon their...k which is expected to be issued soon to the NHS m...
...e anthropologists, from the University of Connecti...arvard University. // They said that Neanderthal...comparable to that of the early modern humans. B...were attributed as a cause for their extinction. T...
...ng developed by scientists belonging to the Northw...es which contribute towards Parkinson's disease. /... issue of the journal Experimental Neurology, was ...tory group at Northwestern University Feinberg Sch...
...cer in India is on the rise and is rapidly becomin...vical cancer to the second spot. The seriousness o...cent data from Indian Council of Medical Research ...d mainly in the metros, but it can be safely said ...
Other Medicine News:
(Date:10/13/2008)...SVILLE, Md., Oct. 13 /- Neuronascent,...day that the Company has received,funding from mul...vel,neurogenic compounds targeting Alzheimer,s di...eceived grants and funding from Maryland,Departmen...nvestment,Program; Maryland Industrial Partnership...
(Date:10/13/2008)...NTON, Mass., Oct. 13 /- Facet Solutio... follow-up on 20 patients from its US,IDE Pilot St...Disability,Index (ODI) scores, and an 80% reductio...g pain. Geoff Pardo, President & CEO for Facet Sol...ly results, which thus far not,only demonstrate si...
(Date:10/10/2008)...Z CREEK, Mich., Oct. 10 /- Diplomat S...cience has selected Diplomat,Specialty Pharmacy to...rge,scale, national Therapy Optimization Study for...wo year TOP MS study, is to examine the benefits o...on compliance, adherence and,patient outcomes. Tar...
(Date:10/9/2008)... American Campaign to Spread Awareness and Bring H...Oct. 9 /PRNewswire-USNewswire/ -- 133 million chil...e to causes such as natural,disaster, civil war, a...is,observing World Orphan Week by calling attentio... Multimedia News Release, go to:, http://www.prn...
Breaking Medicine Technology:Neuronascent, Inc. Receives Multiple Fundings for Its Neurogenesis Therapeutic Programs 2Diplomat Specialty Pharmacy Tapped by Teva Neuroscience for Therapy Optimization Study for Multiple Sclerosis (TOP MS) 2Photos: SOS Children's Villages Observes World Orphan Week, October 5-11, 2008 2U S Meat Industry Will Respond to World Cancer Research Fund Report 707 1HU scientist finds way to catch terrorists red handed 1047 1HU scientist finds way to catch terrorists red handed 1047 2Medivation Announces Participation in Acumen BioFin Rodman 26 Renshaw 9th Annual Healthcare Conference 1605 1Medivation Announces Participation in Acumen BioFin Rodman 26 Renshaw 9th Annual Healthcare Conference 1605 2Stem Cells Restore Memory in Mice 5082 1Stem Cells Restore Memory in Mice 5082 2Stem Cells Restore Memory in Mice 5082 3
... Potent Synergy, Activity and Patient Tolerance Su...ry Therapy, BARCELONA, Spain, April 12, 2007 /PRNe...y held biopharmaceutical company,today announced ...eron with or without ribavirin in treatment-naive ...results demonstrate that,omega interferon in combi...
... SOUTH SAN FRANCISCO, Calif., April 11, 2007 (PRI...biopharmaceutical company focused,on advancing can...ta(tm) (talotrexin) for Injection at the American ...ng April 14-18, 2007 in Los,Angeles, California. ,... with,paclitaxel in A549 non-small cell lung cance...
Other Medicine Technology:Intarcia Therapeutics Announces Final Results From a Phase 2 Study,of Injectable Omega Interferon plus Ribavirin for the Treatment of,Hepatitis C Genotype-1 2Intarcia Therapeutics Announces Final Results From a Phase 2 Study,of Injectable Omega Interferon plus Ribavirin for the Treatment of,Hepatitis C Genotype-1 3Intarcia Therapeutics Announces Final Results From a Phase 2 Study,of Injectable Omega Interferon plus Ribavirin for the Treatment of,Hepatitis C Genotype-1 4Hana Biosciences Announces Data to be Presented On Talvesta,(Talotrexin) for Injection at The American Association for Cancer,Research Annual Meeting 2Hana Biosciences Announces Data to be Presented On Talvesta,(Talotrexin) for Injection at The American Association for Cancer,Research Annual Meeting 3
This unique blanket is designed to be used for many surgical procedures, including but not limited to: laminectomies, spinal procedures, abdominal procedures, and transplants.
The chest access blanket is designed specifically for the thoracic surgery patient.
The cardiac access blanket helps maintain normothermia and allows unrestricted access to the patient.
The adult blanket provides full coverage for patients of all sizes. The generous size and versatility of these blankets include extra material for the shoulders and feet. The foot drape also reduces
Medicine Products: